Biblio

Export 98 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is F  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
M. Fotuhi, Mian, A., Meysami, S., and Raji, C. A., “Neurobiology of COVID-19.”, J Alzheimers Dis, vol. 76, no. 1, pp. 3-19, 2020.
S. Fostinelli, Ciani, M., Zanardini, R., Zanetti, O., Binetti, G., Ghidoni, R., and Benussi, L., “The Heritability of Frontotemporal Lobar Degeneration: Validation of Pedigree Classification Criteria in a Northern Italy Cohort.”, J Alzheimers Dis, vol. 61, no. 2, pp. 753-760, 2018.
I. Fortel, Zhan, L., Ajilore, O., Wu, Y., Mackin, S., and Leow, A., “Disrupted excitation-inhibition balance in cognitively normal individuals at risk of Alzheimer's disease.”, bioRxiv, 2023.
G. Forloni and Balducci, C., “Alzheimer's Disease, Oligomers, and Inflammation.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1261-1276, 2018.
J. Foraker, Millard, S. P., Leong, L., Thomson, Z., Chen, S., C Keene, D., Bekris, L. M., and Yu, C. - E., “The APOE Gene is Differentially Methylated in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
J. C. Fong, Rojas, J. C., Bang, J., Legati, A., Rankin, K. P., Forner, S., Miller, Z. A., Karydas, A. M., Coppola, G., Grouse, C. K., Ralph, J., Miller, B. L., and Geschwind, M. D., “Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.”, J Alzheimers Dis, vol. 55, no. 1, pp. 249-258, 2017.
É. M. Foley, Tripodis, Y., Yhang, E., Koerte, I. K., Martin, B. M., Palmisano, J., Makris, N., Schultz, V., Lepage, C., Muehlmann, M., Wróbel, P. P., Guenette, J. P., Cantu, R. C., Lin, A. P., Coleman, M., Mez, J., Bouix, S., Shenton, M. E., Stern, R. A., and Alosco, M. L., “Quantifying and Examining Reserve in Symptomatic Former National Football League Players.”, J Alzheimers Dis, vol. 85, no. 2, pp. 675-689, 2021.
J. Folch, Busquets, O., Ettcheto, M., Sánchez-López, E., Castro-Torres, R. Dario, Verdaguer, E., Garcia, M. Luisa, Olloquequi, J., Casadesus, G., Beas-Zarate, C., Pelegri, C., Vilaplana, J., Auladell, C., and Camins, A., “Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1223-1240, 2018.
Z. Fodor, Sirály, E., Horváth, A., Salacz, P., Hidasi, Z., Csibri, É., Szabó, Á., and Csukly, G., “Decreased Event-Related Beta Synchronization During Memory Maintenance Marks Early Cognitive Decline in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 2, pp. 489-502, 2018.
M. T. Fodero-Tavoletti, Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C. A., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G., Gong, S., Adlard, P. A., Barnham, K. J., Rowe, C. C., Masters, C. L., Kudo, Y., Cappai, R., Yanai, K., and Villemagne, V. L., “18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.”, Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
H. Florian, Meier, A., Gauthier, S., Lipschitz, S., Lin, Y., Tang, Q., Othman, A. A., Robieson, W. Z., and Gault, L. M., “Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1237-47, 2016.
L. Florek, Tiepolt, S., Schroeter, M. L., Berrouschot, J., Saur, D., Hesse, S., Jochimsen, T., Luthardt, J., Sattler, B., Patt, M., Hoffmann, K. - T., Villringer, A., Classen, J., Gertz, H. - J., Sabri, O., and Barthel, H., “Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1105-1116, 2018.
V. Fleming, Helsel, B. C., Ptomey, L. T., H Rosas, D., Handen, B., Laymon, C., Christian, B. T., Head, E., Mapstone, M., Lai, F., Krinsky-McHale, S., Zaman, S., Ances, B. M., Lee, J. H., and Hartley, S. L., “Weight Loss and Alzheimer's Disease in Down Syndrome.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1215-1227, 2022.
T. Fleiner, Leucht, S., Förstl, H., Zijlstra, W., and Haussermann, P., “Effects of Short-Term Exercise Interventions on Behavioral and Psychological Symptoms in Patients with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1583-1594, 2017.
J. D. Flatt, Johnson, J. K., Karpiak, S. E., Seidel, L., Larson, B., and Brennan-Ing, M., “Correlates of Subjective Cognitive Decline in Lesbian, Gay, Bisexual, and Transgender Older Adults.”, J Alzheimers Dis, vol. 64, no. 1, pp. 91-102, 2018.
M. E. Flanagan, Larson, E. B., Walker, R. L., C Keene, D., Postupna, N., Cholerton, B., Sonnen, J. A., Dublin, S., Crane, P. K., and Montine, T. J., “Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex.”, J Alzheimers Dis, vol. 61, no. 2, pp. 653-662, 2018.
M. E. Flanagan, Cholerton, B., Latimer, C. S., Hemmy, L. S., Edland, S. D., Montine, K. S., White, L. R., and Montine, T. J., “TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1549-1558, 2018.
T. Fladby, Pålhaugen, L., Selnes, P., Waterloo, K., Bråthen, G., Hessen, E., Almdahl, I. Selseth, Arntzen, K. - A., Auning, E., Eliassen, C. Fredrik, Espenes, R., Grambaite, R., Grøntvedt, G. Rolfseng, Johansen, K. Kunszt, Johnsen, S. Harald, Kalheim, L. Flem, Kirsebom, B. - E., Müller, K. Ivar, Nakling, A. Exner, Rongve, A., Sando, S. Botne, Siafarikas, N., Stav, A. Løvli, Tecelao, S., Timon, S., Bekkelund, S. Ivar, and Aarsland, D., “Detecting At-Risk Alzheimer's Disease Cases.”, J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
M. C. Fitzhugh and Pa, J., “Longitudinal Changes in Resting-State Functional Connectivity and Gray Matter Volume Are Associated with Conversion to Hearing Impairment in Older Adults.”, J Alzheimers Dis, vol. 86, no. 2, pp. 905-918, 2022.
N. F. Fitz, Carter, A. Y., Tapias, V., Castranio, E. L., Kodali, R., Lefterov, I., and Koldamova, R., “ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1075-1085, 2017.
C. L. Fisher, Resnick, R. J., De, S., Acevedo, L. A., Lu, K. Ping, Schroeder, F. C., and Nicholson, L. K., “Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.”, J Alzheimers Dis, vol. 55, no. 1, pp. 391-410, 2017.
C. E. Fischer, Qian, W., Schweizer, T. A., Millikin, C. P., Ismail, Z., Smith, E. E., Lix, L. M., Shelton, P., and Munoz, D. G., “Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 1, pp. 283-95, 2016.
F. U. Fischer, Wolf, D., and Fellgiebel, A., “Diaschisis-Like Association of Hippocampal Atrophy and Posterior Cingulate Cortex Hypometabolism in Cognitively Normal Elderly Depends on Impaired Integrity of Parahippocampal Cingulum Fibers.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1285-1294, 2017.
M. Fiorini, Bongianni, M., Benedetti, M. Donata, Monaco, S., and Zanusso, G., “Reappraisal of Aβ40 and Aβ42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 219-227, 2018.
E. Fiorenzato, Biundo, R., Cecchin, D., Frigo, A. Chiara, Kim, J., Weis, L., Strafella, A. P., and Antonini, A., “Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.”, J Alzheimers Dis, vol. 66, no. 1, pp. 229-237, 2018.

Pages